Educational information, not medical advice — ask your doctor or midwife.
Dashamoola Kwath is one of Ayurveda's most revered classical formulas, combining the roots of ten specific plants into a single potent decoction. The name literally means 'ten roots' in Sanskrit, and the formula is described in foundational Ayurvedic texts including the Charaka Samhita and Ashtanga Hridayam. It has been used for thousands of years across South and Southeast Asia as a cornerstone remedy for pain, inflammation, and recovery.
The ten roots work together to calm inflammation, ease muscle and nerve tension, and support the body's ability to clear mucus and toxins. Ayurvedic medicine classifies this formula as tridoshic — meaning it helps restore balance regardless of a person's constitutional type. Modern research suggests the individual roots contain anti-inflammatory compounds, alkaloids, and flavonoids that collectively reduce pain signaling and support immune and respiratory function.
The traditional preparation is a water decoction (kwath) made by simmering the roots in water until reduced. Modern commercial forms include standardized tablets, capsules, and liquid extracts. The decoction is considered the most bioavailable form in classical practice, though tablets and capsules offer convenience. Some formulations are combined with sesame oil for external use or enema therapy (basti) in Panchakarma.
Dashamoola is explicitly prescribed in both the Charaka Samhita and Sushruta Samhita — two of Ayurveda's foundational medical texts written approximately 2,000 years ago. It holds a particularly important place in postpartum care across India, where the decoction is traditionally given to new mothers for several weeks after childbirth to restore strength, reduce inflammation, and support recovery of the uterus and musculoskeletal system.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.